Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

LY 281067

Known as: LY281067 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2001
2001
Background —Mild oxidation of LDL enhances its atherogenic potential and induces a synergistic interaction with serotonin (5HT… Expand
  • figure 1
  • figure 3
  • figure 2
  • figure 4
  • figure 6
Is this relevant?
1999
1999
OBJECTIVES The purpose of this study was to examine whether low density lipoproteins (LDLs) or mildly oxidized LDL (mox-LDL) are… Expand
Is this relevant?
1999
1999
Previous studies have indicated that apart from playing an important role in hemostasis and thrombosis, thrombin may also… Expand
Is this relevant?
1998
1998
Platelet aggregation at sites of vascular injury releases both peptide growth factors and vasoactive compounds. Although… Expand
Is this relevant?
Highly Cited
1997
Highly Cited
1997
BACKGROUND Restenosis is a major complication that limits the long-term efficacy of coronary angioplasty. Migration and… Expand
Is this relevant?
Highly Cited
1989
Highly Cited
1989
The present studies have attempted to evaluate the role of 5-HT2 receptors in the regulation of sexual behavior of male rats by… Expand
Is this relevant?
1989
1989
The ergoline esters, LY53857 [6-methyl-1-(1-methylethyl)ergoline-8-carboxylic acid 2-hydroxy-1-methylpropylester (Z)-2… Expand
Is this relevant?
1988
1988
The preclinical pharmacologic activity of LY281067 shows it to be a potent and highly selective serotonergic (5-HT2) receptor… Expand
Is this relevant?